Q3 2014 Holdings
Filed 2014-11-14 | 62 holdings | $12.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Atricure Inc(ATRC) | CS | 04963C209 | $7.3M | 496,671 | 59.9% |
| Align Technology Inc(ALGN) | CS | 016255101 | $1.8M | 33,934 | 14.4% |
| Biomarin Pharmaceutical Inc(BMRN) | CS | 09061G101 | $1.5M | 20,325 | 12.0% |
| Angiodynamics Inc(ANGO) | CS | 03475V101 | $958.0K | 69,822 | 7.8% |
| Cytokinetics Inc COM(CYTK) | CS | 23282W605 | $581.0K | 165,046 | 4.8% |
| Neogenomics Inc(NEO) | CS | 64049M209 | $13.0K | 2,490,848 | 0.1% |
| IGI Inc | CS | 449575109 | $11.4K | 1,224,503 | 0.1% |
| Spectranetics Corp | CS | 84760C107 | $7.8K | 292,124 | 0.1% |
| Akorn Inc(AKRXEUR) | CS | 009728106 | $7.7K | 213,512 | 0.1% |
| RTI Biologics Inc | CS | 74975N105 | $6.4K | 1,339,291 | 0.1% |
| Enzo Biochem Inc(ENZB) | CS | 294100102 | $5.9K | 1,136,575 | 0.0% |
| Nxstage Medical Inc | CS | 67072V103 | $4.5K | 346,177 | 0.0% |
| Harvard Bioscience Inc(HBIO) | CS | 416906105 | $4.4K | 1,063,840 | 0.0% |
| Streamline Health Solutions | CS | 86323X106 | $3.9K | 846,212 | 0.0% |
| Array Biopharma Inc(ARRYEUR) | CS | 04269X105 | $3.8K | 1,059,270 | 0.0% |
| Ligand Pharmaceuticals Inc(LGND) | CS | 53220K504 | $3.6K | 76,366 | 0.0% |
| Quidel Corp | CS | 74838J101 | $3.6K | 132,885 | 0.0% |
| Techne Corp | CS | 878377100 | $3.4K | 36,566 | 0.0% |
| Spectrum Pharmaceuticals Inc | CS | 84763A108 | $3.1K | 378,537 | 0.0% |
| Tearlab Corp | CS | 878193101 | $3.0K | 896,464 | 0.0% |
| Omnicell Inc(OMCL) | CS | 68213N109 | $3.0K | 111,191 | 0.0% |
| Staar Surgical Co(STAA) | CS | 852312305 | $3.0K | 284,730 | 0.0% |
| Oxford Immunotec Global PLC | CS | G6855A103 | $2.9K | 189,766 | 0.0% |
| Alkermes PLC(ALKS) | CS | G01767105 | $2.8K | 65,423 | 0.0% |
| Sanofi-Synthelabo(SNY) | ADR | 80105N105 | $2.8K | 49,633 | 0.0% |
| Novadaq Technologies Inc | CS | 66987G102 | $2.6K | 208,121 | 0.0% |
| Endologix Inc | CS | 29266S106 | $2.5K | 231,599 | 0.0% |
| Sagent Pharmaceuticals Inc | CS | 786692103 | $2.2K | 70,542 | 0.0% |
| Lannet Inc | CS | 516012101 | $1.9K | 42,656 | 0.0% |
| Celldex Therapeutics Inc New | CS | 15117B103 | $1.9K | 142,811 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | CS | 92532F100 | $1.8K | 16,285 | 0.0% |
| Healthstream Inc(HSTM) | CS | 42222N103 | $1.8K | 76,014 | 0.0% |
| Fluidigm Corp del(LAB) | CS | 34385P108 | $1.8K | 74,482 | 0.0% |
| Cepheid | CS | 15670R107 | $1.8K | 41,272 | 0.0% |
| Advisory BRD Co | CS | 00762W107 | $1.7K | 36,226 | 0.0% |
| Lemaitre Vascular Inc(LMAT) | CS | 525558201 | $1.7K | 242,968 | 0.0% |
| Sunopta Inc(STKL) | CS | 8676EP108 | $1.5K | 122,576 | 0.0% |
| Isis Pharmaceuticals Inc | CS | 464330109 | $1.1K | 27,290 | 0.0% |
| Novartis A G(NVSN) | ADR | 66987V109 | $571 | 6,070 | 0.0% |
| Endo Intl PLC | CS | G30401106 | $558 | 8,161 | 0.0% |
| Aratana Therapeutics Inc(PETXEUR) | CS | 03874P101 | $539 | 53,667 | 0.0% |
| Actavis PLC | CS | G0083B108 | $491 | 2,035 | 0.0% |
| United Therapeutics Corp del(UTHR) | CS | 91307C102 | $491 | 3,820 | 0.0% |
| Wellpoint Inc | CS | 94973V107 | $490 | 4,095 | 0.0% |
| Humana Inc(HUM) | CS | 444859102 | $461 | 3,540 | 0.0% |
| Mylan Labs Inc | CS | 628530107 | $445 | 9,775 | 0.0% |
| Bristol Myers Squibb Co(BMY) | CS | 110122108 | $424 | 8,290 | 0.0% |
| Aetna Inc New | CS | 00817Y108 | $422 | 5,215 | 0.0% |
| Johnson and Johnson(JNJ) | CS | 478160104 | $407 | 3,820 | 0.0% |
| Celgene Corp(CELG) | CS | 151020104 | $406 | 4,280 | 0.0% |